Skip to main navigation
Decibel Therapeutics logo
Menu Button

Top Menu

  • JOIN US
  • CONTACT US

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us

SEC Filings

Filing date Form Description View
February 28, 2022 4

Statement of changes in beneficial ownership of securities

0000899243-22-008086.pdf
0000899243-22-008086.rtf
0000899243-22-008086.xls
View HTML
February 28, 2022 4

Statement of changes in beneficial ownership of securities

0000899243-22-008087.pdf
0000899243-22-008087.rtf
0000899243-22-008087.xls
View HTML
February 14, 2022 SC 13G/A

An amendment to the SC 13G filing

0001104659-22-021112.pdf
0001104659-22-021112.rtf
View HTML
February 14, 2022 SC 13G

A statement of beneficial ownership of common stock by certain persons

0001193125-22-040723.pdf
0001193125-22-040723.rtf
0001193125-22-040723.xls
View HTML
February 14, 2022 SC 13G

A statement of beneficial ownership of common stock by certain persons

0001193125-22-042110.pdf
0001193125-22-042110.rtf
0001193125-22-042110.xls
View HTML
February 11, 2022 SC 13G

A statement of beneficial ownership of common stock by certain persons

0001104659-22-020463.pdf
0001104659-22-020463.rtf
0001104659-22-020463.xls
View HTML
January 4, 2022 4

Statement of changes in beneficial ownership of securities

0000899243-22-000490.pdf
0000899243-22-000490.rtf
0000899243-22-000490.xls
View HTML
December 7, 2021 8-K

Report of unscheduled material events or corporate event

0001193125-21-350436.pdf
0001193125-21-350436.rtf
0001193125-21-350436.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
December 6, 2021 3

Initial filing by director officer or owner of more than ten percent.

0000899243-21-046945.pdf
0000899243-21-046945.rtf
0000899243-21-046945.xls
View HTML
December 6, 2021 3

Initial filing by director officer or owner of more than ten percent.

0000899243-21-046949.pdf
0000899243-21-046949.rtf
0000899243-21-046949.xls
View HTML

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 31 - 40 of 119 results

Data provided by Kaleidoscope.

Shareholder Tools

Contact IR
Contact IR
Email Alerts
Email Alerts
Print Page
Print Page
RSS Feeds
RSS Feeds
Search
Search

© Decibel Therapeutics, Inc. 2023. All rights reserved.

  • Privacy Notice
  • Terms of Use
  • Twitter
  • LinkedIn

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us